Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar
<h3>Introduction</h3><p dir="ltr">Guillain-Barré syndrome (GBS) is an immune-mediated peripheral neuropathy that was reported following meningococcus, polio, influenza and rabies vaccines. However, an association with the COVID-19 vaccine is yet to be established. </p&...
Saved in:
| Main Author: | Almurtada Razok (12204854) (author) |
|---|---|
| Other Authors: | Abdullah Shams (14136646) (author), Ahmed Almeer (21250805) (author), Muhammad Zahid (4510696) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Guillain‐Barré syndrome following COVID‐19 vaccination: An updated systematic review of cases
by: Nour Shaheen (14034758)
Published: (2023) -
Atypical Guillain–Barre syndrome with T6 sensory level
by: Osamah Al‐Ameen (21383678)
Published: (2022) -
COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series
by: Abdel-Naser Elzouki (9376853)
Published: (2021) -
Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis
by: Hany A. Zaki (15954222)
Published: (2023) -
Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination?
by: Maya Aldeeb (14777215)
Published: (2023)